New drug EP395 tested in healthy adults to see how it affects lung inflammation
NCT ID NCT06677918
First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study tested an experimental drug called EP395 in 40 healthy adults. Researchers used a safe, temporary lung inflammation model (inhaled endotoxin) to see how the drug affects immune markers and to check its safety. The goal was to gather early information, not to treat a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Division of Clinical Airway Research
Hanover, 30625, Germany
Conditions
Explore the condition pages connected to this study.